Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. Anais brasileiros de dermatologia. 2012;87(3):425–34.
Article
PubMed
Google Scholar
Vitasa BC, Taylor HR, Strickland PT, Rosenthal FS, West S, Abbey H, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990;65(12):2811–7.
Article
PubMed
CAS
Google Scholar
Ziegler A, Jonason AS, Leffell DJ, Simon JA. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372(6508):773.
Article
PubMed
CAS
Google Scholar
Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(s3):8–12.
Article
PubMed
Google Scholar
Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (“actinic keratosis”). J Am Acad Dermatol. 2000;42:11–7.
Article
PubMed
CAS
Google Scholar
Zalaudek I, Piana S, Moscarella E, Longo C, Zendri E, Castagnetti F, Argenziano G. Morphologic grading and treatment of facial actinic keratosis. Clin Dermatol. 2014;32(1):80–7.
Article
PubMed
Google Scholar
Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses. Eur J Dermatol. 2006;16(6):599–606.
PubMed
CAS
Google Scholar
Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 1998;19(5):723–9.
Article
PubMed
CAS
Google Scholar
Seed MP, Freemantle CN, Alam CA, Colville-Nash PR, et al. Apoptosis induction and inhibition of colon-26 tumour growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro & in vivo and topical diclofenac in hyaluronan. In: Sinzinger H, Samuelsson B, Vane JR, Paoletti R, Ramwell P, Wong PY-K, editors. Recent advances in prostaglandin, thromboxane, and leukotriene research. New York: Springer, 1997. pp 339–342.
Nelson C, Rigel D, Smith S, Swanson N, Wolf J. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol. 2003;3(4):401–7.
Google Scholar
Campione E, Diluvio L, Paterno EJ, Chimenti S. Topical treatment of actinic keratoses with piroxicam 1% gel. Am J Clin Dermatol. 2010;11(1):45–50.
Article
PubMed
Google Scholar
Babino G, Diluvio L, Bianchi L, Orlandi A, Di Prete M, Chimenti S, Campione E. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study. Curr Med Res Opin. 2016;32(8):1345–9.
Article
PubMed
CAS
Google Scholar
Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Prev Biomark. 1997;6(11):949–56.
CAS
Google Scholar
Szeimiesa RM, Karrera S, Radakovic-Fijanb S, Tanewb A, Calzavara-Pintonc PG, Zanec C, Mefferth H. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47(2):258–62.
Article
Google Scholar
Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis—an update. Br J Dermatol. 2007;157(s2):18–20.
Article
PubMed
CAS
Google Scholar
Moy LS, Murad H, Moy RL. Glycolic acid peels for the treatment of wrinkles and photoaging. J Dermatol Surg Oncol. 1993;19(3):243–6.
Article
PubMed
CAS
Google Scholar
Swinehart JM. Salicylic acid ointment peeling of the hands and forearms: effective nonsurgical removal of pigmented lesions and actinic damage. J Dermatol Surg Oncol. 1992;18(6):495–8.
Article
PubMed
CAS
Google Scholar
Linming F, Wei H, Anqi L, et al. Comparison of two skin imaging analysis instruments: the VISIA from Canfield vs the ANTERA 3D CS from Miravex. Skin Res Technol. 2018;24(1):3–8.
Article
PubMed
CAS
Google Scholar
Fu W, Cockerell CJ. The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol. 2003;139(1):66–70.
Article
PubMed
Google Scholar
Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1):S8–10.
Article
Google Scholar
Dirschka T, Gupta G, Micali G, Stockfleth E, Basset-Séguin N, Del Marmol V, et al. Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. J Dermatol Treat. 2017;28(5):431–42.
Article
Google Scholar
Jetter N, Chandan N, Wang S, Tsoukas M. Field Cancerization therapies for management of actinic keratosis: a narrative review. Am J Clin Dermatol 2018. https://doi.org/10.1007/s40257-018-0348-7.
De Berker D, McGregor JM, Hughes BR, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156(2):222–30.
Article
PubMed
CAS
Google Scholar
Garofalo V, Ventura A, Mazzilli S, Diluvio L, Bianchi L, Toti L, Campione E. Treatment of multiple actinic keratosis and field of cancerization with topical piroxicam 0.8% and sunscreen 50+ in organ transplant recipients: a series of 10 cases. Case Rep Dermatol. 2017;9(3):211–6.
Article
PubMed
PubMed Central
Google Scholar
Ianhez M, Fleury Junior LFF, Miot HA, Bagatin E. Retinoids for prevention and treatment of actinic keratosis. Anais brasileiros de dermatologia. 2013;88(4):585–93.
Article
PubMed
PubMed Central
Google Scholar
Lens M, Medenica L. Systemic retinoids in chemoprevention of non-melanoma skin cancer. Expert Opin Pharmacother. 2008;9(8):1363–74.
Article
PubMed
CAS
Google Scholar
Mrass P, Rendl M, Mildner M, Gruber F, Lengauer B, Ballaun C, Tschachler E. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Can Res. 2004;64(18):6542–8.
Article
CAS
Google Scholar